Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04344795 |
Title | Phase 1a/1b Study of TPST-1495 Alone and With Pembrolizumab in Subjects With Solid Tumors |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Tempest Therapeutics |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Colorado | Aurora | Colorado | 80045 | United States | Details | |
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine | Baltimore | Maryland | 21287 | United States | Details | |
Baystate Gynecologic Oncology | Springfield | Massachusetts | 01107 | United States | Details | |
University of Michigan Rogel Cancer Center | Ann Arbor | Michigan | 48109 | United States | Details | |
START Midwest | Grand Rapids | Michigan | 49546 | United States | Details | |
Carolina BioOncology Institute | Huntersville | North Carolina | 28078 | United States | Details | |
SCRI-OK Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
University of Pennsylvania Perelman School of Medicine | Philadelphia | Pennsylvania | 19104 | United States | Details | |
University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | United States | Details | |
Tennessee Oncology | Nashville | Tennessee | 37203 | United States | Details | |
South Texas Accelerated Research Therapeutics (START) | San Antonio | Texas | 78229 | United States | Details |